NIH Awards $17.1M for Biomedical Research at Children's Hospital Medical Center Over 10 Years
Contract Overview
Contract Amount: $17,107,556 ($17.1M)
Contractor: Childrens Hospital Medical Center
Awarding Agency: Department of Health and Human Services
Start Date: 2007-11-01
End Date: 2017-09-30
Contract Duration: 3,621 days
Daily Burn Rate: $4.7K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 13
Pricing Type: COST NO FEE
Sector: R&D
Official Description: BIOMEDICAL (APPLIED/EXPLORATORY)
Place of Performance
Location: CINCINNATI, HAMILTON County, OHIO, 45229
State: Ohio Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $17.1 million to CHILDRENS HOSPITAL MEDICAL CENTER for work described as: BIOMEDICAL (APPLIED/EXPLORATORY) Key points: 1. Significant long-term investment in biomedical research. 2. Competition method indicates potential for fair pricing. 3. Risk is moderate given the long duration and R&D nature. 4. Biotechnology sector sees substantial R&D funding.
Value Assessment
Rating: good
The contract value of $17.1M over 10 years averages $1.71M annually. This appears reasonable for a large-scale biomedical research project at a major medical center, though specific benchmarks are difficult without more granular data.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
Full and open competition was utilized, suggesting a robust process for selecting the contractor and establishing pricing. This method generally leads to competitive pricing and better value for taxpayers.
Taxpayer Impact: The competitive nature of the award is positive for taxpayer value, ensuring funds are used efficiently for research.
Public Impact
Advances critical biomedical research in biotechnology. Supports a leading medical institution in research and development. Potential for breakthroughs impacting public health.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Long contract duration increases risk of cost overruns or scope creep.
- Research and Development projects inherently carry uncertainty of outcome.
- Lack of specific performance metrics makes outcome assessment difficult.
Positive Signals
- Full and open competition promotes fair pricing.
- Significant investment in a critical research area.
- Partnership with a reputable medical center.
Sector Analysis
This contract falls within the Biotechnology (NAICS 541711) sector, which is characterized by high R&D investment and long development cycles. Spending in this area is crucial for scientific advancement and public health.
Small Business Impact
The data does not indicate any specific involvement or benefit to small businesses in this contract. The awardee is a large medical center, suggesting the primary focus was on institutional capacity.
Oversight & Accountability
The contract was awarded by the Department of Health and Human Services through the National Institutes of Health, indicating established oversight mechanisms for federal research funding. However, the long duration necessitates ongoing monitoring.
Related Government Programs
- Research and Development in Biotechnology
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Long contract duration (10 years) increases risk.
- R&D projects have inherent uncertainty of success.
- Cost No Fee contract type may not incentivize efficiency.
- Lack of specific performance metrics.
- Potential for scope creep over a decade.
Tags
research-and-development-in-biotechnolog, department-of-health-and-human-services, oh, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $17.1 million to CHILDRENS HOSPITAL MEDICAL CENTER. BIOMEDICAL (APPLIED/EXPLORATORY)
Who is the contractor on this award?
The obligated recipient is CHILDRENS HOSPITAL MEDICAL CENTER.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $17.1 million.
What is the period of performance?
Start: 2007-11-01. End: 2017-09-30.
What specific research milestones or deliverables were defined in the contract to ensure accountability and measure progress?
The provided data does not detail specific research milestones or deliverables. For a contract of this magnitude and duration, clearly defined objectives, interim reports, and final outcomes are crucial for assessing the value and effectiveness of the taxpayer investment. Without this information, it's challenging to gauge the return on investment beyond the general advancement of the research field.
How were potential cost overruns managed given the 10-year R&D timeline and 'Cost No Fee' contract type?
The 'Cost No Fee' (CNF) contract type typically means the contractor is reimbursed for allowable costs but receives no fee or profit. This structure is often used when the scope of work is uncertain, as in R&D. Managing cost overruns would rely heavily on robust oversight from NIH, strict adherence to approved budgets, and potentially contract modifications if significant unforeseen issues arise.
What is the anticipated impact of this research on specific public health challenges or medical advancements?
The data identifies the research area as 'Biotechnology (Applied/Exploratory)' but does not specify the exact public health challenges or medical advancements targeted. The impact is therefore broad, potentially contributing to new treatments, diagnostic tools, or a deeper understanding of diseases. The long-term nature suggests foundational research that may lead to future breakthroughs.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 13
Pricing Type: COST NO FEE (S)
Evaluated Preference: NONE
Contractor Details
Address: 3333 BURNET AVE, CINCINNATI, OH, 45229
Business Categories: Category Business, Educational Institution, Higher Education, Nonprofit Organization, Not Designated a Small Business
Financial Breakdown
Contract Ceiling: $33,104,908
Exercised Options: $33,104,908
Current Obligation: $17,107,556
Contract Characteristics
Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED
Timeline
Start Date: 2007-11-01
Current End Date: 2017-09-30
Potential End Date: 2017-09-30 00:00:00
Last Modified: 2019-09-27
More Contracts from Childrens Hospital Medical Center
- R&d-Other SVC & Develop-Adv DEV — $16.7M (Department of Health and Human Services)
View all Childrens Hospital Medical Center federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →